Compare Bath & Body Works Inc (BBWI) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? Bath & Body Works Inc trades at $18.9 (market cap $3.81B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Bath & Body Works Inc is far larger — about 7.5× Ginkgo Bioworks Holdings Inc's market cap, and Bath & Body Works Inc pays a 4.24% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| BBWI | DNA | |
|---|---|---|
Market Cap | $3.81B | $505.73M |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $16.14 |
52-Week Low | $14.85 | $5.48 |
Enterprise Value | $7.70B | $607.68M |
Dividend Yield | 4.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
